Bookmark this page — the only place tracking real acceptance speed, FWCI and field-normalized citation data for this journal.

Journal decision profile

Cancer Immunology Research

Medicine · Immunology and Microbiology

American Association for Cancer ResearchUnited StatespISSN 2326-6066eISSN 2326-6074

Visit homepage

2.22026 metrics scoreOpenAlex · CC0

223dmedian speedlatest 95 articles

$—publishing cost*verify with journal

Journal Metrics Score

Journal Metrics ScoreThe visible value is the 2026Journal Metrics Score: citations in the most recent complete year to the journal's works from the two prior years, divided by the number of those works — from OpenAlex open data (CC0).

2026

2.2

Journal Metrics Score 2026 · 2021–2024 window citedness 3.46.

Speed

SpeedMedian calendar days from manuscript received to accepted. It includes revision time and is not the journal's time to first decision.

PUBMED

223 days

Submission → acceptance · median · 95/100 recent articles.

APC / cost*

APC / cost*Costs are indicative and may exclude taxes, waivers, society discounts, or article-type charges. Always verify the journal's official website.

VERIFY

Not available

No reliable journal-level APC is cached. Cost is excluded from scoring.

At a glance

Journal decision profile

A visual summary for comparison—not a single black-box star rating.

Relative profile

Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible

Metrics Score

Metrics ScoreThe 2026 Journal Metrics Score, normalized within a comparable journal cohort for this preview.

2.22026 · OPENALEX

Source output rank

Source output rankLifetime journal-wide output rank among OpenAlex sources associated with the journal’s leading topic.

#109 / 1,358LIFETIME OUTPUT

Highly cited papers

Highly cited papersRecent works in the global top 10% after normalization by work type, year, and subfield.

18.4%FIELD-NORMALIZED TOP 10%

Field-normalized impact

Field-normalized impactMedian FWCI, where 1.0 is the expected citation level for comparable work.

1.58MEDIAN FWCI

Review speed

Review speedMedian submission-to-acceptance time from qualified PubMed records.

223 daysMEDIAN

Recent output

Recent outputAverage annual publication volume across the complete analysis window.

276 / yr2021–2024 AVG

Cost efficiency

Cost efficiencyNo score is assigned without a reliable journal-level cost.

—NOT SCORED

Field-normalized top 10% share18.4%

203 of 1,102 works · same type, year & subfield

Field-normalized top 1% share0.6%

7 works · same type, year & subfield

Median FWCI1.58×

Above field-year expectation

Source output rank#109

of 1,358 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 1.58, so its typical recent paper runs about 58% above its field benchmark.

What does Top 10% Share mean?

18.4% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Submission to acceptance time (publication speed)

Among 95 recent articles with complete PubMed dates, the median time from received to accepted was 223 days. It includes revisions and is not the journal's time to first decision.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

7722016

2772017

3082018

6402019

5782020

2342021

3632022

2342023

2712024

4512025

Recent work-type mix

1,102 OpenAlex works · 2021–2024

Article51.1%

Conference abstract47.6%

Paratext0.4%

Erratum0.3%

Other0.3%

Review0.3%

OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.

Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

NeoplasmsTumor MicroenvironmentMelanomaT-LymphocytesImmunotherapy, AdoptiveLung NeoplasmsImmune Checkpoint InhibitorsReceptors, Chimeric AntigenCD8-Positive T-Lymphocytes

Leading OpenAlex topics

2021–2024 works

Cancer Immunotherapy and Biomarkers179

CAR-T cell therapy research159

Immune Cell Function and Interaction97

Immunotherapy and Immune Responses80

Immune cells in cancer70

Cancer Research and Treatments22

interferon and immune responses19

Single-cell and spatial transcriptomics19

Virus-based gene therapy research18

Cancer Genomics and Diagnostics17

Methodology: OpenAlex snapshot 2026-08-09. FWCI, percentile badges, topics, and type mix use 1,102 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.